1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Nasopharyngeal Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fan, CW; Jiang, JC; Li, MS; Tang, J; Wang, HS; Zhou, MM | 1 |
1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
Topics: Animals; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glycogen Synthase Kinase 3 beta; Humans; Hydrolyzable Tannins; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; p38 Mitogen-Activated Protein Kinases; TOR Serine-Threonine Kinases | 2022 |